275 related articles for article (PubMed ID: 15922311)
1. Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
Christoph T; Reissmüller E; Schiene K; Englberger W; Chizh BA
Brain Res; 2005 Jun; 1048(1-2):218-27. PubMed ID: 15922311
[TBL] [Abstract][Full Text] [Related]
2. The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism.
Christoph T; Schiene K; Englberger W; Parsons CG; Chizh BA
Neuropharmacology; 2006 Jul; 51(1):12-7. PubMed ID: 16616769
[TBL] [Abstract][Full Text] [Related]
3. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
4. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain.
Xing GG; Liu FY; Qu XX; Han JS; Wan Y
Exp Neurol; 2007 Dec; 208(2):323-32. PubMed ID: 17936754
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
Lee HG; Park SK; Yoon MH
Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
[TBL] [Abstract][Full Text] [Related]
6. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
7. Contribution by DRt descending facilitatory pathways to maintenance of spinal neuron sensitization in rats.
Sotgiu ML; Valente M; Storchi R; Caramenti G; Mario Biella GE
Brain Res; 2008 Jan; 1188():69-75. PubMed ID: 18054897
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain.
Hopkins SC; Zhao FY; Bowen CA; Fang X; Wei H; Heffernan ML; Spear KL; Spanswick DC; Varney MA; Large TH
J Pharmacol Exp Ther; 2013 Jun; 345(3):502-11. PubMed ID: 23520265
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats.
Jhaveri MD; Elmes SJ; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):361-70. PubMed ID: 16045489
[TBL] [Abstract][Full Text] [Related]
10. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
[TBL] [Abstract][Full Text] [Related]
11. Spinal D-amino acid oxidase contributes to neuropathic pain in rats.
Zhao WJ; Gao ZY; Wei H; Nie HZ; Zhao Q; Zhou XJ; Wang YX
J Pharmacol Exp Ther; 2010 Jan; 332(1):248-54. PubMed ID: 19828879
[TBL] [Abstract][Full Text] [Related]
12. Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats.
Werner MF; Kassuya CA; Ferreira J; Zampronio AR; Calixto JB; Rae GA
Neuropharmacology; 2007 Jul; 53(1):48-57. PubMed ID: 17555775
[TBL] [Abstract][Full Text] [Related]
13. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
Blackburn-Munro G; Bomholt SF; Erichsen HK
Neuropharmacology; 2004 Sep; 47(3):351-62. PubMed ID: 15275824
[TBL] [Abstract][Full Text] [Related]
14. Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain.
Li W; Neugebauer V
Pain; 2004 Jul; 110(1-2):112-22. PubMed ID: 15275758
[TBL] [Abstract][Full Text] [Related]
15. Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia.
Lee DH; Singh JP; Lodge D
Neurosci Lett; 2005 Sep; 385(3):179-83. PubMed ID: 15964141
[TBL] [Abstract][Full Text] [Related]
16. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
17. The analgesic action of topical diclofenac may be mediated through peripheral NMDA receptor antagonism.
Dong XD; Svensson P; Cairns BE
Pain; 2009 Dec; 147(1-3):36-45. PubMed ID: 19766393
[TBL] [Abstract][Full Text] [Related]
18. Peripheral glutamate receptors contribute to mechanical hyperalgesia in a neuropathic pain model of the rat.
Jang JH; Kim DW; Sang Nam T; Se Paik K; Leem JW
Neuroscience; 2004; 128(1):169-76. PubMed ID: 15450364
[TBL] [Abstract][Full Text] [Related]
19. Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat.
Lee SE; Kim JH
Neurosci Res; 2007 Jul; 58(3):245-9. PubMed ID: 17428562
[TBL] [Abstract][Full Text] [Related]
20. Unilateral subcutaneous bee venom but not formalin injection causes contralateral hypersensitized wind-up and after-discharge of the spinal withdrawal reflex in anesthetized spinal rats.
You HJ; Arendt-Nielsen L
Exp Neurol; 2005 Sep; 195(1):148-60. PubMed ID: 15950221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
